CRP and breast cancer: High levels of CRP and cytokines (mainly IL6, IL1ß, and sTNF-RII) have been also reported in others studies among breast cancer survivors with cognitive impairment that suggested a dysregulation of the immune system as a possible mechanism of onset of cognitive decline [100,101].